Sarah R. Sincero, BSc (she/her/hers)

Scientist
AstraZeneca
Gaithersburg, Maryland, United States

Sarah joined AstraZeneca in 2022 and is a Senior Scientist within the Translational Medicine group as part of the AstraZeneca Vaccines and Immune Therapies unit. Sarah’s research focuses on the monitoring of phenotypic resistance of viral variants, including RSV, through clinical exploratory and surveillance endpoints. Sarah received her BS in Biological Sciences from University of Maryland, Baltimore County in 2020.

Disclosure information not submitted.

Presentation(s):

• 185 - Nirsevimab Binding Site Conservation in RSV F Protein between 2019 and 2024: Analysis of Sequencing Data from the US OUTSMART-RSV Surveillance Study and Public Databases

  Monday, October 20, 2025
  2:45 PM - 2:57 PM US ET